BKA
AVNS

Brick & Kyle Associates’s Avanos Medical AVNS Stock Holding History

Brick & Kyle Associates’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-100
Closed -$4K – 114
2017
Q1 		$4K Hold
100
– – ﹤0.01% 380
2016
Q4 		$4K Hold
100
– – ﹤0.01% 386
2016
Q3 		$3K Hold
100
– – ﹤0.01% 398
2016
Q2 		$3K Sell
100
-136
-58% -$4.17K ﹤0.01% 404
2016
Q1 		$7K Sell
236
-62
-21% -$1.65K 0.01% 361
2015
Q4 		$10K Sell
298
-118
-28% -$3.67K 0.01% 334
2015
Q3 		$12K Sell
416
-49
-11% -$1.71K 0.01% 323
2015
Q2 		$19K Hold
465
– – 0.02% 287
2015
Q1 		$23K Sell
465
-72
-13% -$3.33K 0.02% 256
2014
Q4 		$24K Buy
+537
New +$21.1K 0.02% 242

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Brick & Kyle Associates's AVNS Position: Q2 2017 in Review

Brick & Kyle Associates sold out of Avanos Medical (AVNS) in Q2 2017, closing a stake of 100 shares — an estimated $4K sold.

Brick & Kyle Associates first reported a position in AVNS in Q4 2014 and held it in 10 quarters. The position peaked at $24K in Q4 2014. 328 funds tracked by Wall St. Rank hold AVNS as of Q2 2017.

  • Brick & Kyle Associates reported no remaining Avanos Medical position as of Q2 2017 after selling out during the quarter.
  • Brick & Kyle Associates sold 100 Avanos Medical shares in Q2 2017, an estimated $4K.
  • Brick & Kyle Associates first reported a position in Avanos Medical in Q4 2014 and held it in 10 quarters.
  • Brick & Kyle Associates's Avanos Medical position peaked at $24K in Q4 2014.
  • 328 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2017.

Based on Brick & Kyle Associates's 13F filing for Q2 2017, filed 14 Aug 2017.